AIRS vs BMRN · rev $82.3M vs P/E 40, rev $1.76B
Airsculpt Technologies Inc (AIRS) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Airsculpt Technologies Inc (AIRS) is a medical care facilities company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported AIRS revenue for 2026-06-30 was $82.3M. Net income was -$3.5M. AIRS currently screens at market cap $337.0M.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
AIRS currently screens at market cap $337.0M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the AIRS and BMRN stock pages for the full models.
Not investment advice.